TRASTUZUMAB, Tislelizumab, Oxaliplatin 5 mg/ml concentrate for solution for infusion, LOPERAMIDE, JZP598, CAPECITABINE
ZWI-ZW25-301
Phase 3 small_molecule active
Quick answer
TRASTUZUMAB, Tislelizumab, Oxaliplatin 5 mg/ml concentrate for solution for infusion, LOPERAMIDE, JZP598, CAPECITABINE for Gastroesophageal Adenocarcinoma (GEA) is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals Ireland Limited
- Indication
- Gastroesophageal Adenocarcinoma (GEA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active